Efforts to improve study cohorts have included the adoption of standardized criteria such as the Canadian Consensus Criteria (CCC) and the CDC-1994 criteria (Carruthers et al., 1994)
10.1007/s10534-018-0111-9 Summary Keywords lactoferrin, Parkinson's disease, neuroprotection, heparan sulfate proteoglycans, dopaminergic cells, MPTP Citation Eker F, Bolat E, Pekdemir B, Duman H and Karav S (2023) Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment
J Urol 189:803811 Wigner P, Grbowski R, Bijak M, Szemraj J, Saluk-Bijak J (2021) The molecular aspect of nephrolithiasis development
The service and all products and services delivered to you through the service are (except as expressly stated by us) provided 'as is' and 'as available' for your use, without any representation, warranties or conditions of any kind, either express or implied, including all implied warranties or conditions of merchantability, merchantable quality, fitness for a particular purpose, durability, title, and non-infringement
Your provider identifies which vitamins are deficient in your blood panel and prescribes accordingly
Individual study citations and links are maintained in our internal editorial reference log and are available on request
